Key Takeaways

• Zymeworks has entered into an agreement to purchase Theravance Biopharma in an all-cash transaction valued at $929 million at $17 per share
• Acquisition pricing represents a 3.6% decrease compared to Theravance’s previous closing price of $17.63
• Yupelri, Theravance’s sole commercialized product for COPD treatment approved by FDA, recorded $266.6 million in 2025 U.S. net revenue
• Premarket trading showed Theravance shares declining 2.8% while Zymeworks decreased 1.4%
• Transaction completion is anticipated during the latter half of 2026 and projected to boost Zymeworks’ earnings and cash generation

In a significant consolidation move, Zymeworks has reached a definitive agreement to purchase Theravance Biopharma through an all-cash transaction totaling $929 million, offering shareholders $17 per share — representing a 3.6% reduction from Theravance’s Friday closing value of $17.63.

Zymeworks Inc., ZYME

Investor sentiment reflected skepticism. During Monday’s premarket session, Theravance shares declined 2.8% to $17.14. Zymeworks experienced a 1.4% pullback.

The below-market pricing is atypical in merger and acquisition activity and clarifies the negative market reaction. Most buyout transactions include a premium above current trading levels.

Neverthstanding, the transaction does provide a 22% markup relative to Theravance’s March 3 valuation, immediately following the announcement of late-stage clinical trial disappointment for ampreloxetine — a therapy candidate targeting a rare medical condition.

The unsuccessful trial prompted Theravance to initiate a corporate reorganization, resulting in workforce reductions of approximately 50%. Subsequently, management commenced a strategic review process, including potential sale scenarios.

Monday’s announcement effectively concludes that strategic evaluation period.

Assets Acquired by Zymeworks

The centerpiece of this transaction is Yupelri, a nebulized once-daily medication for chronic obstructive pulmonary disease already available commercially. This represents Theravance’s only marketed pharmaceutical product.

Yupelri achieved $266.6 million in U.S. net revenue during 2025, reflecting 12% growth versus the prior year. First quarter 2026 U.S. net revenue reached $62.4 million, demonstrating 7% year-over-year expansion.

Theravance maintains a 35% net profit participation arrangement for Yupelri within the United States, where commercialization occurs through a partnership with Viatris. According to Zymeworks, these royalty streams and profit-sharing arrangements currently deliver approximately $60 million in annualized cash generation.

This acquisition represents a strategic pivot for Zymeworks — historically concentrated in oncology therapeutics — establishing presence in the respiratory disease sector alongside major pharmaceutical companies like GSK, AstraZeneca, and Boehringer Ingelheim.

Future of Ampreloxetine Program

The unsuccessful development candidate remains part of the transaction structure. Under deal terms, Theravance shareholders will obtain contingent value rights entitling them to 80% of net proceeds resulting from future licensing arrangements, asset sales, or alternative monetization transactions involving ampreloxetine during the next decade.

Zymeworks retains the remaining 20% interest and has indicated intentions to explore monetization opportunities for this asset.

Zymeworks management projects the acquisition will enhance earnings and cash flow generation following transaction completion, targeted for the second half of 2026.

Completion remains contingent upon regulatory clearance and approval from Theravance shareholders.

Yupelri’s first quarter 2026 U.S. net revenue performance of $62.4 million marked 7% advancement compared to the corresponding period in the previous year.

Strategy (MSTR) unveiled a new Digital Credit Capital Framework on Monday, introducing a series of capital management initiatives designed to strengthen its preferred securities, preserve long term bitcoin exposure, and improve balance sheet flexibility.

The company has already adopted a board approved U.S. dollar reserve policy and increased the annual dividend rate on its Variable Rate Series A Perpetual Stretch Preferred Stock (STRC) to 12%, effective for dividend periods beginning July 1. Strategy said its U.S. dollar reserve currently stands at approximately $2.55 billion, enough to cover about 17.4 months of preferred dividend and interest obligations.

The board also authorized, but did not commit to, up to $1 billion in repurchases of its Digital Credit Securities and up to $1 billion in buybacks of its Class A common stock. The programs have no fixed expiration date and may be modified, suspended, or terminated at any time. Actual repurchases will depend on market conditions and management’s assessment that they are accretive.

IRACE is not alone in betting that institutions want fewer providers and more integrated infrastructure. In April, SoFi unveiled Big Business Banking, a platform that lets companies manage fiat banking and crypto-related operations through a single regulated bank. The service signed up major digital asset firms including CoinDesk’s parent company Bullish (BLSH), BitGo (BTGO), Cumberland and Wintermute, highlighting a broader industry move toward combining traditional banking, payments and digital asset services under one roof.

As part of the rebrand, IRACE appointed former Zodia Custody CEO John Cronin as global CEO. Several other former Zodia executives, including Jo Lee, Niamh Byrne and Jennifer Fisher, have also joined the company in senior leadership roles.

“Institutional clients today are forced to stitch together banking, custody, payments, liquidity and execution across multiple providers, each with its own controls, reporting and operational risk,” Cronin said in the release.

“IRACE is being built to unify that stack into a single institutional platform — one operating model, one governance framework, one set of controls — supporting fiat, stablecoins, and both traditional and digital assets. That is what institutional scale across these markets actually requires,” he added.

IRACE operates regulated banking businesses across the U.S., Europe and the Cayman Islands. The company said it is pursuing additional regulatory approvals related to digital asset services in multiple jurisdictions.

The crypto market outlook remains fragile. Rising concerns about Federal Reserve interest-rate increases, a strengthening dollar, higher U.S. Treasury yields, record ETF outflows and airstrikes in the Middle East offer bitcoin BTC$59,717.65 bulls little reason for optimism.

Yet the market dynamics carry a glimmer of hope.

Bullish positioning, especially in the Dollar Index and interest-rate markets, is beginning to look lopsided. That’s the kind of crowded setup that often unwinds with a snap adjustment and a contrarian, counter-trend move. Should that occur, it would probably take the form of a sudden drop in the dollar and yields, which could put a strong floor under bitcon’s price.

The crowding shows up clearly in the data. Figures from the CFTC and ICE Europe show the aggregate net long dollar position rose 18% to $34.5 billion in the week ended June 22, the highest in seven years. That’s a sharp reversal from the net short position before the Iran conflict began in February.

Rates markets tell a similar story. Leveraged funds’ short bets in Secured Overnight Financing Rate (SOFR) futures hit a record 2.97 million contracts. That constitutes over $700 billion in notional bets on rising interest rates, according to Saxo Bank.

Everyone is watching the CLARITY Act for what it does to crypto market structure. Buried inside it is a provision with a different target entirely: a ban on a US central bank digital currency. It is literally one of the bill’s three names. Here is what the anti-CBDC provision does, why it is there, and why it may matter more for stablecoins than for anything else.

Almost everyone watching the CLARITY Act is watching it for one reason: it would settle the long fight over whether crypto tokens are securities or commodities, reshaping how the entire digital-asset market is regulated. That is the headline, and it is a big one. But folded inside the same bill is a provision aimed at something completely different, a ban on a United States central bank digital currency, and it is not a minor footnote. 

The anti-CBDC language is so integral to the legislation that it is one of the bill’s three official short titles: the same act is named the Digital Asset Market Clarity Act, the CLARITY Act, and the Anti-CBDC Surveillance State Act. In other words, stopping a government digital dollar is not a rider quietly attached to the bill; it is one of the bill’s stated purposes, written into its very name. Yet because the market-structure debate consumes nearly all the attention, the CBDC ban has traveled largely under the radar, which is exactly why it is worth examining on its own.

The reason this matters extends well beyond a technical change to the Federal Reserve Act. A ban on a US central bank digital currency touches some of the most charged questions in money today: financial privacy, government surveillance, the future of the dollar, and, most concretely for crypto, the competitive fate of private stablecoins. Removing the possibility of a government-issued digital dollar does not just settle a privacy debate; it clears the field of the one competitor that could have challenged the private stablecoins now becoming central to crypto and payments. 

This piece explains what the anti-CBDC provision actually does, what a central bank digital currency is and why it generates such fierce opposition, the political case behind the ban, the bigger prize of a protected lane for private stablecoins, the several parallel tracks on which the ban is moving, the serious arguments against it, and what it all means for crypto holders. The market-structure fight may decide how crypto is regulated, but the CBDC provision could quietly shape who wins the payments future, which makes it one of the most consequential parts of the bill almost nobody is discussing.

What the provision actually does

Start with the mechanics, because the provision is specific. The anti-CBDC language amends the Federal Reserve Act to impose several related prohibitions on the central bank. It bars the Federal Reserve banks from offering certain products or services directly to individuals, which is the structural feature a retail digital dollar would require, since a true retail CBDC would mean ordinary people holding accounts or balances directly with the Fed. 

It prohibits the Fed from issuing a central bank digital currency, or any digital asset substantially similar to one, directly to individuals or indirectly through financial institutions or other intermediaries. It prohibits the use of a central bank digital currency to conduct monetary policy. And in its fuller forms, the anti-CBDC framework also bars the Fed from even testing or developing a CBDC without explicit authorization from Congress.

Bitcoin is heading toward the end of June with traders focused on a potential make-or-break area near $60,000—an important level that bulls have struggled to defend as bearish momentum has carried into the second quarter. At the same time, several widely watched momentum and onchain signals are flashing early “stabilization” clues that could complicate the bearish narrative.

Technical traders point to bullish divergences in RSI across multiple time frames, while onchain analytics from CryptoQuant highlights a “first bottoming flag” tied to how broadly Bitcoin’s unspent outputs remain in profit versus loss. Separately, macro traders are preparing for a tight window of economic releases—especially the U.S. manufacturing PMI—and the market’s sensitivity to U.S. labor data and geopolitical developments.

Key takeaways

• RSI divergences are appearing across several time frames in Bitcoin’s charts, an indication that selling pressure may be losing traction.
• June’s performance has been weak—CoinGlass data cited in the report shows nearly a 19% loss for BTC/USD in June, its worst since the 2022 bear market.
• Traders are comparing the current $60,000 test to prior bear-market behavior, arguing that support often breaks only after repeated attempts.
• CryptoQuant says a UTXO profitability indicator is at its lowest level since 2022, suggesting an early stage of internal “market clean-up.”
• Seasonality research cited by traders suggests July has historically been a better month than June in many years, though outcomes can vary.

RSI divergences revive recovery odds as June nears its close

As June approaches its end, analysts and traders are watching whether Bitcoin can hold a key structural level. According to TradingView data cited in earlier coverage, RSI signals across multiple time frames are showing bullish divergences—instances where price behavior and momentum diverge in a way that historically can precede reversals or at least a pause in decline.

Cointelegraph previously reported that RSI cues across time frames are aligning into bullish divergences with price as June ends. The article also referenced a comment from Bitcoin whale “Gerla” (CryptoGerla) on X, saying the four-hour chart is showing a bullish RSI divergence while a potential double bottom forms.

Other traders have emphasized that such divergence signals have not consistently appeared in prior dips during 2026. Pseudonymous commentator “Heisenberg” noted on X that recent oversold RSI divergences had not shown up in the same way during earlier drops—until the current setup—suggesting the present decline may be maturing rather than simply accelerating.

Still, the presence of divergences is not the same as confirmation. The same coverage points out that $60,000 has increasingly acted as resistance, with bulls unable to push through decisively—an issue that keeps traders wary of a breakdown scenario heading into month-end.

Why $60,000 matters: the “mid-2022” support test comparison

One reason traders treat the $60,000 level as more than just a psychological number is historical patterning. In the source reporting, commentators compared the current situation to 2022, when Bitcoin repeatedly interacted with the $30,000 area before it finally failed and later produced a bear-market low.

CoinGlass data cited in the article places Bitcoin’s June drawdown at nearly 19% for BTC/USD—described as the worst since the 2022 bear market and the sharpest performance so far this year. That framing matters because it puts current price weakness into context: the market is not just drifting lower, it is experiencing a month that resembles the intensity of prior major risk-off phases.

On X, commentator “Exitpump” argued that significant support and resistance levels rarely break on the first attempt, often requiring repeated tests before momentum flips decisively. The same post likened the current $60,000 dynamics to the way $30,000 behaved earlier in the 2022 cycle. Importantly, the argument here is conditional: even if June is fragile, it may not be a single-day event that determines the next trend leg.

Macro pressure points: PMI, labor data, and geopolitical risk

Even with technical setups improving, Bitcoin’s short-term direction often depends on what happens in U.S. economic data. The source highlights a “short but busy” four-day trading week ending Q2, with the manufacturing PMI as a potential swing factor.

According to the report, the Institute for Supply Management (ISM) is set to publish the manufacturing Purchasing Managers Index (PMI) on Wednesday. The source notes that the PMI has been breaking out from a multiyear downtrend and that estimates call for a score around the mid-50s, with a possible mild decrease versus the prior month. In prior coverage, Cointelegraph had described PMI strength as a potential tailwind for crypto markets.

Thursday’s June nonfarm payrolls report is another key focus. As trading resource The Kobeissi Letter summarized in a thread on X, the market is also set to react to geopolitical developments as the U.S. and Iran agree to discuss their fragile peace agreement. The same note tied the week’s schedule to the end of Q2, with earnings season on the horizon—factors that can amplify cross-asset volatility.

The report also stresses that Bitcoin’s correlation with equities has been inconsistent in recent months, and it includes an example of trader Daan Crypto Trades pointing to BTC versus the S&P 500 returning to a level seen during earlier risk-stress periods. That matters for investors because it implies the market may not be moving in a straight line with stock indices—meaning both crypto-specific and macro drivers can compete.

Seasonality and “first bottoming flag” signals: early stabilization vs. full reversal

Two separate narratives are being used to explain why July could look different from June. The first is historical seasonality. The source cites research shared by Rekt Capital on X, arguing that in previous years July has often offset June’s weakness—sometimes followed by August weakness that cancels July’s upside. CoinGlass data referenced in the article supports this pattern by showing only a few exceptions since 2013, while 2025 is noted as a case where both months finished green.

The second narrative is onchain. The report highlights a CryptoQuant QuickTake post by contributor I. Moreno, who described an “early clear sign” of deeper market clean-up. Moreno focuses on the UTXO Block P/L Count Ratio Model, an indicator that compares how blocks of unspent outputs are distributed between profit and loss across the network.

In Moreno’s explanation as quoted in the source, a high ratio can indicate many UTXO blocks still sit in profit—often associated with higher distribution risk. When the ratio falls toward lower ranges, profitability compresses, losses spread more widely, and the market enters a more advanced reset phase.

The report states that the ratio is currently 5.9, described as the lowest since 2022 and one of the lowest readings on record, which Moreno called Bitcoin’s “first bottoming flag” of the current bear market. However, the same source cautions that this may only indicate the start of internal reset rather than the completion of a full bottom—history suggests additional stress absorption may still be required.

What this combination of signals implies is not certainty, but a shift in balance: momentum indicators are improving at the same time an onchain metric suggests distribution pressure may be moving into an earlier phase of exhaustion. The unresolved question is whether $60,000 holds long enough for those signs to translate into a sustained reversal.

Going forward, traders and investors should watch month-end price acceptance around $60,000, the immediate reaction to U.S. PMI and labor data, and whether the RSI divergences persist as July starts—alongside onchain follow-through on the “bottoming flag” theme highlighted by CryptoQuant.